Showing results (301-310 of 867) with videos related to
Sort By:
Pageof 87
The Annals of Thoracic Surgery|December 27, 2019
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve-Induced Thrombin GenerationIqbal H Jaffer, James C Fredenburgh, Alan Stafford, et al.Journal of Thrombosis and Haemostasis : JTH|March 24, 2020
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysisEmanuele Valeriani, Ettore Porreca, Jeffrey I Weitz, et al.JAMA Cardiology|March 30, 2017
Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A ReviewJohn W Eikelboom, Daniel J Quinlan, Jack Hirsh, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis ModelRan Ni, Nima Vaezzadeh, Ji Zhou, et al.Journal of Thrombosis and Thrombolysis|July 15, 2009
Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugsMark Y Chan, Jeffrey I Weitz, Yahye Merhi, et al.Circulation|April 10, 2002
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular eventsJohn W Eikelboom, Jack Hirsh, Jeffrey I Weitz, et al.Chest|February 9, 2012
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesJohn W Eikelboom, Jack Hirsh, Frederick A Spencer, et al.Haematologica|August 6, 2002
Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemiaRosanna Asselta, Silvia Spena, Stefano Duga, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2022
The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patientsMaria Teresa Pagliari, Luciano Baronciani, Chiara Cordiglieri, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 4, 2023
A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complicationsMaria Abbattista, Marco Capecchi, Francesca Gianniello, et al.Pageof 87